PERMIT has launched a brief survey to to map patient stratification strategies currently undertaken by industry. It will contribute to a better understanding of the challenges and opportunities in the translational development phase of personalised medicine clinical trials. The results will be discussed during a workshop in which field experts and key stakeholders will develop recommendations for the establishment of industry-based translational strategies in personalised medicine.
The survey consists of only 14 questions, and requires approximately 10 minutes to answer. It is fully anonymous, and can be accessed via the following link:
The survey will remain open until the end of November 2020. If you wish to have further information on this survey or the workshop where its results will be discussed, please send an email to email@example.com.